Holdings (Monthly)
Guide ↗
Invesco Nasdaq Biotechnology ETF
· Invesco Exchange-Traded Fund Trust II| # | Name | Ticker | Since | Shares | Value | % Port | Cat |
|---|---|---|---|---|---|---|---|
| 1 | Invesco Private Prime Fund | N/A | Feb 2026 | 10,825,717 | $10.8M | 14.29% | STIV |
| 2 | Gilead Sciences, Inc. | 375558103 | Feb 2026 | 48,865 | $7.3M | 9.61% | EC |
| 3 | Vertex Pharmaceuticals Inc. | 92532F100 | Feb 2026 | 14,178 | $7.0M | 9.30% | EC |
| 4 | Amgen Inc. | 031162100 | Feb 2026 | 17,796 | $6.9M | 9.12% | EC |
| 5 | Regeneron Pharmaceuticals, Inc. | 75886F107 | Feb 2026 | 5,839 | $4.6M | 6.03% | EC |
| 6 | Invesco Private Government Fund | N/A | Feb 2026 | 4,201,477 | $4.2M | 5.55% | STIV |
| 7 | Alnylam Pharmaceuticals, Inc. | 02043Q107 | Feb 2026 | 7,470 | $2.5M | 3.28% | EC |
| 8 | Insmed Inc. | 457669307 | Feb 2026 | 12,065 | $1.8M | 2.38% | EC |
| 9 | Biogen Inc. | 09062X103 | Feb 2026 | 8,295 | $1.6M | 2.10% | EC |
| 10 | argenx SE | 04016X101 | Feb 2026 | 1,648 | $1.3M | 1.67% | EC |
| 11 | United Therapeutics Corp. | 91307C102 | Feb 2026 | 2,437 | $1.2M | 1.62% | EC |
| 12 | Moderna, Inc. | 60770K107 | Feb 2026 | 22,109 | $1.2M | 1.56% | EC |
| 13 | Illumina, Inc. | 452327109 | Feb 2026 | 8,646 | $1.2M | 1.53% | EC |
| 14 | Roivant Sciences Ltd. | G76279101 | Feb 2026 | 39,369 | $1.1M | 1.50% | EC |
| 15 | Incyte Corp. | 45337C102 | Feb 2026 | 11,115 | $1.1M | 1.49% | EC |
| 16 | Royalty Pharma PLC | G7709Q104 | Feb 2026 | 24,171 | $1.1M | 1.47% | EC |
| 17 | Revolution Medicines, Inc. | 76155X100 | Feb 2026 | 10,938 | $1.1M | 1.47% | EC |
| 18 | Viatris Inc. | 92556V106 | Feb 2026 | 65,178 | $973K | 1.28% | EC |
| 19 | Ascendis Pharma A/S | 04351P101 | Feb 2026 | 3,474 | $811K | 1.07% | EC |
| 20 | Neurocrine Biosciences, Inc. | 64125C109 | Feb 2026 | 5,641 | $746K | 0.98% | EC |
| 21 | Ionis Pharmaceuticals, Inc. | 462222100 | Feb 2026 | 9,163 | $744K | 0.98% | EC |
| 22 | Sanofi | 80105N105 | Feb 2026 | 14,988 | $729K | 0.96% | EC |
| 23 | BridgeBio Pharma, Inc. | 10806X102 | Feb 2026 | 10,918 | $726K | 0.96% | EC |
| 24 | Medpace Holdings, Inc. | 58506Q109 | Feb 2026 | 1,593 | $720K | 0.95% | EC |
| 25 | Summit Therapeutics Inc. | 86627T108 | Feb 2026 | 42,174 | $700K | 0.92% | EC |
| 26 | Guardant Health, Inc. | 40131M109 | Feb 2026 | 7,319 | $687K | 0.91% | EC |
| 27 | BioMarin Pharmaceutical Inc. | 09061G101 | Feb 2026 | 10,885 | $672K | 0.89% | EC |
| 28 | Exelixis, Inc. | 30161Q104 | Feb 2026 | 15,175 | $669K | 0.88% | EC |
| 29 | Jazz Pharmaceuticals PLC | G50871105 | Feb 2026 | 3,442 | $654K | 0.86% | EC |
| 30 | BioNTech SE | 09075V102 | Feb 2026 | 5,726 | $631K | 0.83% | EC |
| 31 | BeOne Medicines Ltd. | 07725L102 | Feb 2026 | 1,784 | $566K | 0.75% | EC |
| 32 | Madrigal Pharmaceuticals, Inc. | 558868105 | Feb 2026 | 1,287 | $556K | 0.73% | EC |
| 33 | ImmunityBio, Inc. | 45256X103 | Feb 2026 | 55,881 | $547K | 0.72% | EC |
| 34 | Tempus AI, Inc. | 88023B103 | Feb 2026 | 9,809 | $522K | 0.69% | EC |
| 35 | Arrowhead Pharmaceuticals, Inc. | 04280A100 | Feb 2026 | 7,676 | $486K | 0.64% | EC |
| 36 | Praxis Precision Medicines, Inc. | 74006W207 | Feb 2026 | 1,420 | $478K | 0.63% | EC |
| 37 | Axsome Therapeutics, Inc. | 05464T104 | Feb 2026 | 2,849 | $467K | 0.62% | EC |
| 38 | Halozyme Therapeutics, Inc. | 40637H109 | Feb 2026 | 6,671 | $464K | 0.61% | EC |
| 39 | Vaxcyte, Inc. | 92243G108 | Feb 2026 | 7,425 | $458K | 0.61% | EC |
| 40 | Krystal Biotech, Inc. | 501147102 | Feb 2026 | 1,646 | $454K | 0.60% | EC |
| 41 | Cytokinetics, Inc. | 23282W605 | Feb 2026 | 6,884 | $428K | 0.57% | EC |
| 42 | Nuvalent, Inc. | 670703107 | Feb 2026 | 4,101 | $418K | 0.55% | EC |
| 43 | Abivax S.A. | 00370M103 | Feb 2026 | 3,337 | $405K | 0.53% | EC |
| 44 | Arcellx, Inc. | 03940C100 | Feb 2026 | 3,276 | $373K | 0.49% | EC |
| 45 | Kymera Therapeutics, Inc. | 501575104 | Feb 2026 | 4,067 | $372K | 0.49% | EC |
| 46 | Rhythm Pharmaceuticals, Inc. | 76243J105 | Feb 2026 | 3,774 | $350K | 0.46% | EC |
| 47 | Cogent Biosciences, Inc. | 19240Q201 | Feb 2026 | 8,738 | $339K | 0.45% | EC |
| 48 | Protagonist Therapeutics, Inc. | 74366E102 | Feb 2026 | 3,560 | $328K | 0.43% | EC |
| 49 | CRISPR Therapeutics AG | H17182108 | Feb 2026 | 5,417 | $326K | 0.43% | EC |
| 50 | Caris Life Sciences, Inc. | 142152107 | Feb 2026 | 15,855 | $319K | 0.42% | EC |
| 51 | PTC Therapeutics, Inc. | 69366J200 | Feb 2026 | 4,553 | $310K | 0.41% | EC |
| 52 | Alkermes PLC | G01767105 | Feb 2026 | 9,274 | $279K | 0.37% | EC |
| 53 | Immunovant, Inc. | 45258J102 | Feb 2026 | 9,812 | $272K | 0.36% | EC |
| 54 | CG Oncology, Inc. | 156944100 | Feb 2026 | 4,605 | $271K | 0.36% | EC |
| 55 | Mirum Pharmaceuticals, Inc. | 604749101 | Feb 2026 | 2,923 | $270K | 0.36% | EC |
| 56 | Scholar Rock Holding Corp. | 80706P103 | Feb 2026 | 5,710 | $253K | 0.33% | EC |
| 57 | Amicus Therapeutics, Inc. | 03152W109 | Feb 2026 | 17,240 | $248K | 0.33% | EC |
| 58 | Amneal Pharmaceuticals, Inc. | 03168L105 | Feb 2026 | 17,835 | $246K | 0.33% | EC |
| 59 | Structure Therapeutics Inc. | 86366E106 | Feb 2026 | 3,736 | $235K | 0.31% | EC |
| 60 | Acadia Pharmaceuticals Inc. | 004225108 | Feb 2026 | 9,567 | $235K | 0.31% | EC |
| 61 | Indivior Pharmaceuticals, Inc. | 45579U109 | Feb 2026 | 6,991 | $229K | 0.30% | EC |
| 62 | NewAmsterdam Pharma Co. N.V. | N62509109 | Feb 2026 | 6,442 | $228K | 0.30% | EC |
| 63 | Crinetics Pharmaceuticals, Inc. | 22663K107 | Feb 2026 | 5,407 | $222K | 0.29% | EC |
| 64 | Ligand Pharmaceuticals Inc. | 53220K504 | Feb 2026 | 1,101 | $218K | 0.29% | EC |
| 65 | Erasca, Inc. | 29479A108 | Feb 2026 | 15,831 | $216K | 0.29% | EC |
| 66 | Apogee Therapeutics, Inc. | 03770N101 | Feb 2026 | 3,075 | $215K | 0.28% | EC |
| 67 | Terns Pharmaceuticals, Inc. | 880881107 | Feb 2026 | 5,023 | $212K | 0.28% | EC |
| 68 | ADMA Biologics, Inc. | 000899104 | Feb 2026 | 13,305 | $207K | 0.27% | EC |
| 69 | Xenon Pharmaceuticals Inc. | 98420N105 | Feb 2026 | 4,390 | $190K | 0.25% | EC |
| 70 | Spyre Therapeutics, Inc. | 00773J202 | Feb 2026 | 4,352 | $187K | 0.25% | EC |
| 71 | Arcutis Biotherapeutics, Inc. | 03969K108 | Feb 2026 | 6,836 | $184K | 0.24% | EC |
| 72 | Edgewise Therapeutics, Inc. | 28036F105 | Feb 2026 | 5,934 | $181K | 0.24% | EC |
| 73 | Tarsus Pharmaceuticals, Inc. | 87650L103 | Feb 2026 | 2,367 | $179K | 0.24% | EC |
| 74 | Supernus Pharmaceuticals, Inc. | 868459108 | Feb 2026 | 3,195 | $175K | 0.23% | EC |
| 75 | Denali Therapeutics Inc. | 24823R105 | Feb 2026 | 8,178 | $173K | 0.23% | EC |
| 76 | Veracyte, Inc. | 92337F107 | Feb 2026 | 4,424 | $162K | 0.21% | EC |
| 77 | Beam Therapeutics Inc. | 07373V105 | Feb 2026 | 5,686 | $162K | 0.21% | EC |
| 78 | Alumis Inc. | 022307102 | Feb 2026 | 5,443 | $162K | 0.21% | EC |
| 79 | Twist Bioscience Corp. | 90184D100 | Feb 2026 | 3,416 | $160K | 0.21% | EC |
| 80 | IDEAYA Biosciences, Inc. | 45166A102 | Feb 2026 | 4,907 | $158K | 0.21% | EC |
| 81 | 10x Genomics, Inc. | 88025U109 | Feb 2026 | 6,513 | $150K | 0.20% | EC |
| 82 | Travere Therapeutics, Inc. | 89422G107 | Feb 2026 | 4,995 | $149K | 0.20% | EC |
| 83 | Apellis Pharmaceuticals, Inc. | 03753U106 | Feb 2026 | 7,068 | $148K | 0.20% | EC |
| 84 | Vera Therapeutics, Inc. | 92337R101 | Feb 2026 | 3,585 | $146K | 0.19% | EC |
| 85 | Centessa Pharmaceuticals PLC | 152309100 | Feb 2026 | 5,405 | $145K | 0.19% | EC |
| 86 | Disc Medicine, Inc. | 254604101 | Feb 2026 | 2,105 | $140K | 0.19% | EC |
| 87 | Adaptive Biotechnologies Corp. | 00650F109 | Feb 2026 | 8,546 | $137K | 0.18% | EC |
| 88 | Wave Life Sciences Ltd. | Y95308105 | Feb 2026 | 9,352 | $130K | 0.17% | EC |
| 89 | Mineralys Therapeutics, Inc. | 603170101 | Feb 2026 | 4,428 | $130K | 0.17% | EC |
| 90 | Ultragenyx Pharmaceutical Inc. | 90400D108 | Feb 2026 | 5,405 | $126K | 0.17% | EC |
| 91 | Dyne Therapeutics, Inc. | 26818M108 | Feb 2026 | 7,965 | $124K | 0.16% | EC |
| 92 | Maze Therapeutics, Inc. | 578784100 | Feb 2026 | 2,678 | $122K | 0.16% | EC |
| 93 | Stoke Therapeutics, Inc. | 86150R107 | Feb 2026 | 3,184 | $116K | 0.15% | EC |
| 94 | GRAIL, Inc. | 384747101 | Feb 2026 | 2,176 | $116K | 0.15% | EC |
| 95 | Kiniksa Pharmaceuticals International, PLC | G52694109 | Feb 2026 | 2,538 | $113K | 0.15% | EC |
| 96 | Harrow, Inc. | 415858109 | Feb 2026 | 2,072 | $112K | 0.15% | EC |
| 97 | Olema Pharmaceuticals, Inc. | 68062P106 | Feb 2026 | 4,401 | $107K | 0.14% | EC |
| 98 | Ocular Therapeutix, Inc. | 67576A100 | Feb 2026 | 11,885 | $106K | 0.14% | EC |
| 99 | Syndax Pharmaceuticals, Inc. | 87164F105 | Feb 2026 | 4,873 | $106K | 0.14% | EC |
| 100 | Recursion Pharmaceuticals, Inc. | 75629V104 | Feb 2026 | 28,735 | $105K | 0.14% | EC |
| 101 | Aurinia Pharmaceuticals Inc. | 05156V102 | Feb 2026 | 7,358 | $104K | 0.14% | EC |
| 102 | BioCryst Pharmaceuticals, Inc. | 09058V103 | Feb 2026 | 11,766 | $103K | 0.14% | EC |
| 103 | Pharvaris N.V. | N69605108 | Feb 2026 | 3,591 | $102K | 0.13% | EC |
| 104 | Vericel Corp. | 92346J108 | Feb 2026 | 2,833 | $101K | 0.13% | EC |
| 105 | Relay Therapeutics, Inc. | 75943R102 | Feb 2026 | 9,680 | $99K | 0.13% | EC |
| 106 | Enliven Therapeutics, Inc. | 29337E102 | Feb 2026 | 3,328 | $99K | 0.13% | EC |
| 107 | Tyra Biosciences, Inc. | 90240B106 | Feb 2026 | 2,966 | $99K | 0.13% | EC |
| 108 | Agios Pharmaceuticals, Inc. | 00847X104 | Feb 2026 | 3,239 | $98K | 0.13% | EC |
| 109 | Sarepta Therapeutics, Inc. | 803607100 | Feb 2026 | 5,837 | $98K | 0.13% | EC |
| 110 | Zymeworks Inc. | 98985Y108 | Feb 2026 | 4,184 | $97K | 0.13% | EC |
| 111 | Definium Therapeutics, Inc. | 24477V105 | Feb 2026 | 5,503 | $96K | 0.13% | EC |
| 112 | Innoviva, Inc. | 45781M101 | Feb 2026 | 4,181 | $96K | 0.13% | EC |
| 113 | Genmab A/S | 372303206 | Feb 2026 | 3,245 | $96K | 0.13% | EC |
| 114 | ANI Pharmaceuticals, Inc. | 00182C103 | Feb 2026 | 1,263 | $93K | 0.12% | EC |
| 115 | Amylyx Pharmaceuticals, Inc. | 03237H101 | Feb 2026 | 6,115 | $93K | 0.12% | EC |
| 116 | Oruka Therapeutics, Inc. | 687604108 | Feb 2026 | 2,692 | $93K | 0.12% | EC |
| 117 | Novavax, Inc. | 670002401 | Feb 2026 | 9,091 | $92K | 0.12% | EC |
| 118 | Sionna Therapeutics, Inc. | 829401108 | Feb 2026 | 2,514 | $92K | 0.12% | EC |
| 119 | Harmony Biosciences Holdings, Inc. | 413197104 | Feb 2026 | 3,206 | $91K | 0.12% | EC |
| 120 | Nurix Therapeutics, Inc. | 67080M103 | Feb 2026 | 5,681 | $91K | 0.12% | EC |
| 121 | RAPT Therapeutics, Inc. | 75382E208 | Feb 2026 | 1,551 | $90K | 0.12% | EC |
| 122 | Legend Biotech Corp. | 52490G102 | Feb 2026 | 4,707 | $89K | 0.12% | EC |
| 123 | Ardelyx, Inc. | 039697107 | Feb 2026 | 13,580 | $89K | 0.12% | EC |
| 124 | Intellia Therapeutics, Inc. | 45826J105 | Feb 2026 | 6,453 | $89K | 0.12% | EC |
| 125 | NovoCure Ltd. | G6674U108 | Feb 2026 | 6,261 | $86K | 0.11% | EC |
| 126 | AnaptysBio, Inc. | 032724106 | Feb 2026 | 1,550 | $85K | 0.11% | EC |
| 127 | Iovance Biotherapeutics, Inc. | 462260100 | Feb 2026 | 22,091 | $85K | 0.11% | EC |
| 128 | Trevi Therapeutics, Inc. | 89532M101 | Feb 2026 | 7,146 | $85K | 0.11% | EC |
| 129 | Tango Therapeutics Inc. | 87583X109 | Feb 2026 | 7,535 | $84K | 0.11% | EC |
| 130 | MBX Biosciences, Inc. | 55287L101 | Feb 2026 | 2,526 | $82K | 0.11% | EC |
| 131 | EyePoint, Inc. | 30233G209 | Feb 2026 | 4,637 | $81K | 0.11% | EC |
| 132 | Kodiak Sciences Inc. | 50015M109 | Feb 2026 | 2,951 | $79K | 0.10% | EC |
| 133 | Immunocore Holdings PLC | 45258D105 | Feb 2026 | 2,432 | $79K | 0.10% | EC |
| 134 | Zenas Biopharma, Inc. | 98937L105 | Feb 2026 | 2,980 | $79K | 0.10% | EC |
| 135 | Rapport Therapeutics, Inc. | 75383L102 | Feb 2026 | 2,657 | $77K | 0.10% | EC |
| 136 | Corvus Pharmaceuticals, Inc. | 221015100 | Feb 2026 | 4,177 | $76K | 0.10% | EC |
| 137 | Precigen, Inc. | 74017N105 | Feb 2026 | 19,747 | $75K | 0.10% | EC |
| 138 | Collegium Pharmaceutical, Inc. | 19459J104 | Feb 2026 | 1,776 | $74K | 0.10% | EC |
| 139 | AtaiBeckley Inc. | 04650F101 | Feb 2026 | 20,269 | $74K | 0.10% | EC |
| 140 | ORIC Pharmaceuticals, Inc. | 68622P109 | Feb 2026 | 5,451 | $73K | 0.10% | EC |
| 141 | Septerna, Inc. | 81734D104 | Feb 2026 | 2,520 | $73K | 0.10% | EC |
| 142 | Vir Biotechnology, Inc. | 92764N102 | Feb 2026 | 7,785 | $71K | 0.09% | EC |
| 143 | Alvotech | L01800108 | Feb 2026 | 17,492 | $70K | 0.09% | EC |
| 144 | Taysha Gene Therapies Inc. | 877619106 | Feb 2026 | 15,289 | $69K | 0.09% | EC |
| 145 | Savara Inc. | 805111101 | Feb 2026 | 11,348 | $68K | 0.09% | EC |
| 146 | Monte Rosa Therapeutics, Inc. | 61225M102 | Feb 2026 | 3,640 | $65K | 0.09% | EC |
| 147 | Sana Biotechnology, Inc. | 799566104 | Feb 2026 | 14,886 | $63K | 0.08% | EC |
| 148 | Grifols, S.A. | 398438408 | Feb 2026 | 6,813 | $62K | 0.08% | EC |
| 149 | Phibro Animal Health Corp. | 71742Q106 | Feb 2026 | 1,124 | $61K | 0.08% | EC |
| 150 | Day One Biopharmaceuticals, Inc. | 23954D109 | Feb 2026 | 5,740 | $61K | 0.08% | EC |
| 151 | AbCellera Biologics Inc. | 00288U106 | Feb 2026 | 16,724 | $60K | 0.08% | EC |
| 152 | Geron Corp. | 374163103 | Feb 2026 | 35,647 | $60K | 0.08% | EC |
| 153 | Inhibrx Biosciences, Inc. | 45720N103 | Feb 2026 | 807 | $60K | 0.08% | EC |
| 154 | UroGen Pharma Ltd. | M96088105 | Feb 2026 | 2,613 | $57K | 0.07% | EC |
| 155 | Xeris Biopharma Holdings, Inc. | 98422E103 | Feb 2026 | 9,253 | $57K | 0.07% | EC |
| 156 | MannKind Corp. | 56400P706 | Feb 2026 | 17,136 | $56K | 0.07% | EC |
| 157 | Ventyx Biosciences, Inc. | 92332V107 | Feb 2026 | 3,977 | $56K | 0.07% | EC |
| 158 | Fortrea Holdings Inc. | 34965K107 | Feb 2026 | 5,176 | $55K | 0.07% | EC |
| 159 | uniQure N.V. | N90064101 | Feb 2026 | 3,468 | $54K | 0.07% | EC |
| 160 | ArriVent Biopharma, Inc. | 04272N102 | Feb 2026 | 2,313 | $53K | 0.07% | EC |
| 161 | Pacira Biosciences, Inc. | 695127100 | Feb 2026 | 2,398 | $53K | 0.07% | EC |
| 162 | Amphastar Pharmaceuticals, Inc. | 03209R103 | Feb 2026 | 2,574 | $52K | 0.07% | EC |
| 163 | Theravance Biopharma Inc. | G8807B106 | Feb 2026 | 2,837 | $52K | 0.07% | EC |
| 164 | Bicara Therapeutics Inc. | 055477103 | Feb 2026 | 3,072 | $52K | 0.07% | EC |
| 165 | Cullinan Therapeutics, Inc. | 230031106 | Feb 2026 | 3,316 | $51K | 0.07% | EC |
| 166 | GH Research PLC | G3855L106 | Feb 2026 | 3,456 | $51K | 0.07% | EC |
| 167 | ARS Pharmaceuticals, Inc. | 82835W108 | Feb 2026 | 5,518 | $51K | 0.07% | EC |
| 168 | Xencor, Inc. | 98401F105 | Feb 2026 | 3,980 | $51K | 0.07% | EC |
| 169 | CytomX Therapeutics, Inc. | 23284F105 | Feb 2026 | 9,460 | $51K | 0.07% | EC |
| 170 | Arbutus Biopharma Corp. | 03879J100 | Feb 2026 | 10,743 | $50K | 0.07% | EC |
| 171 | Phathom Pharmaceuticals, Inc. | 71722W107 | Feb 2026 | 3,967 | $50K | 0.07% | EC |
| 172 | Castle Biosciences, Inc. | 14843C105 | Feb 2026 | 1,619 | $48K | 0.06% | EC |
| 173 | Arvinas, Inc. | 04335A105 | Feb 2026 | 3,599 | $48K | 0.06% | EC |
| 174 | Omeros Corp. | 682143102 | Feb 2026 | 3,957 | $48K | 0.06% | EC |
| 175 | Prime Medicine, Inc. | 74168J101 | Feb 2026 | 10,067 | $47K | 0.06% | EC |
| 176 | KalVista Pharmaceuticals, Inc. | 483497103 | Feb 2026 | 2,831 | $46K | 0.06% | EC |
| 177 | Janux Therapeutics, Inc. | 47103J105 | Feb 2026 | 3,365 | $46K | 0.06% | EC |
| 178 | Annexon, Inc. | 03589W102 | Feb 2026 | 8,089 | $45K | 0.06% | EC |
| 179 | Personalis, Inc. | 71535D106 | Feb 2026 | 4,964 | $45K | 0.06% | EC |
| 180 | BioAge Labs, Inc. | 09077V100 | Feb 2026 | 2,018 | $45K | 0.06% | EC |
| 181 | Esperion Therapeutics, Inc. | 29664W105 | Feb 2026 | 13,354 | $45K | 0.06% | EC |
| 182 | Mesoblast Ltd. | 590717401 | Feb 2026 | 2,721 | $43K | 0.06% | EC |
| 183 | Kura Oncology, Inc. | 50127T109 | Feb 2026 | 4,878 | $43K | 0.06% | EC |
| 184 | Zai Lab Ltd. | 98887Q104 | Feb 2026 | 2,174 | $42K | 0.06% | EC |
| 185 | Invesco Government & Agency Portfolio | 825252885 | Feb 2026 | 39,488 | $39K | 0.05% | STIV |
| 186 | COMPASS Pathways PLC | 20451W101 | Feb 2026 | 5,259 | $36K | 0.05% | EC |
| 187 | Rigel Pharmaceuticals, Inc. | 766559702 | Feb 2026 | 1,019 | $35K | 0.05% | EC |
| 188 | Allogene Therapeutics, Inc. | 019770106 | Feb 2026 | 12,556 | $35K | 0.05% | EC |
| 189 | MeiraGTx Holdings PLC | G59665102 | Feb 2026 | 4,490 | $34K | 0.04% | EC |
| 190 | Replimune Group, Inc. | 76029N106 | Feb 2026 | 4,391 | $34K | 0.04% | EC |
| 191 | Design Therapeutics, Inc. | 25056L103 | Feb 2026 | 3,177 | $33K | 0.04% | EC |
| 192 | Neumora Therapeutics, Inc. | 640979100 | Feb 2026 | 9,348 | $33K | 0.04% | EC |
| 193 | CorMedix Inc. | 21900C308 | Feb 2026 | 4,414 | $31K | 0.04% | EC |
| 194 | Ironwood Pharmaceuticals, Inc. | 46333X108 | Feb 2026 | 9,099 | $31K | 0.04% | EC |
| 195 | 4D Molecular Therapeutics, Inc. | 35104E100 | Feb 2026 | 3,185 | $31K | 0.04% | EC |
| 196 | Rocket Pharmaceuticals, Inc. | 77313F106 | Feb 2026 | 6,041 | $30K | 0.04% | EC |
| 197 | Vanda Pharmaceuticals Inc. | 921659108 | Feb 2026 | 3,317 | $30K | 0.04% | EC |
| 198 | Lexeo Therapeutics, Inc. | 52886X107 | Feb 2026 | 4,094 | $29K | 0.04% | EC |
| 199 | Lyell Immunopharma, Inc. | 55083R203 | Feb 2026 | 1,207 | $29K | 0.04% | EC |
| 200 | Maravai LifeSciences Holdings, Inc. | 56600D107 | Feb 2026 | 8,103 | $29K | 0.04% | EC |
| 201 | Pacific Biosciences of California, Inc. | 69404D108 | Feb 2026 | 16,852 | $28K | 0.04% | EC |
| 202 | Zevra Therapeutics, Inc. | 488445206 | Feb 2026 | 3,142 | $28K | 0.04% | EC |
| 203 | Kamada Ltd. | M6240T109 | Feb 2026 | 3,210 | $28K | 0.04% | EC |
| 204 | Aquestive Therapeutics, Inc. | 03843E104 | Feb 2026 | 6,813 | $27K | 0.04% | EC |
| 205 | Solid Biosciences Inc. | 83422E204 | Feb 2026 | 4,366 | $27K | 0.04% | EC |
| 206 | Galapagos N.V. | 36315X101 | Feb 2026 | 803 | $27K | 0.04% | EC |
| 207 | Invivyd, Inc. | 00534A102 | Feb 2026 | 15,472 | $26K | 0.03% | EC |
| 208 | Prothena Corp. PLC | G72800108 | Feb 2026 | 2,992 | $26K | 0.03% | EC |
| 209 | SIGA Technologies, Inc. | 826917106 | Feb 2026 | 3,989 | $26K | 0.03% | EC |
| 210 | Eton Pharmaceuticals, Inc. | 29772L108 | Feb 2026 | 1,510 | $26K | 0.03% | EC |
| 211 | REGENXBIO Inc. | 75901B107 | Feb 2026 | 2,835 | $26K | 0.03% | EC |
| 212 | Fulcrum Therapeutics, Inc. | 359616109 | Feb 2026 | 3,042 | $25K | 0.03% | EC |
| 213 | Entrada Therapeutics, Inc. | 29384C108 | Feb 2026 | 2,126 | $25K | 0.03% | EC |
| 214 | Larimar Therapeutics, Inc. | 517125100 | Feb 2026 | 4,770 | $25K | 0.03% | EC |
| 215 | Altimmune, Inc. | 02155H200 | Feb 2026 | 5,817 | $25K | 0.03% | EC |
| 216 | Tectonic Therapeutic, Inc. | 878972108 | Feb 2026 | 1,045 | $25K | 0.03% | EC |
| 217 | Keros Therapeutics, Inc. | 492327101 | Feb 2026 | 1,724 | $24K | 0.03% | EC |
| 218 | PepGen Inc. | 713317105 | Feb 2026 | 3,853 | $24K | 0.03% | EC |
| 219 | LENZ Therapeutics, Inc. | 52635N103 | Feb 2026 | 1,768 | $24K | 0.03% | EC |
| 220 | Upstream Bio, Inc. | 91678A107 | Feb 2026 | 3,038 | $23K | 0.03% | EC |
| 221 | AbSci Corp. | 00091E109 | Feb 2026 | 8,394 | $23K | 0.03% | EC |
| 222 | Enanta Pharmaceuticals, Inc. | 29251M106 | Feb 2026 | 1,604 | $23K | 0.03% | EC |
| 223 | Anavex Life Sciences Corp. | 032797300 | Feb 2026 | 4,989 | $22K | 0.03% | EC |
| 224 | Aura Biosciences, Inc. | 05153U107 | Feb 2026 | 3,566 | $21K | 0.03% | EC |
| 225 | Atea Pharmaceuticals, Inc. | 04683R106 | Feb 2026 | 4,376 | $20K | 0.03% | EC |
| 226 | Kyverna Therapeutics, Inc. | 501976104 | Feb 2026 | 2,433 | $20K | 0.03% | EC |
| 227 | Neurogene Inc. | 64135M105 | Feb 2026 | 848 | $20K | 0.03% | EC |
| 228 | Contineum Therapeutics, Inc. | 21217B100 | Feb 2026 | 1,293 | $20K | 0.03% | EC |
| 229 | Autolus Therapeutics PLC | 05280R100 | Feb 2026 | 11,218 | $19K | 0.03% | EC |
| 230 | NovaBridge Biosciences | 44975P103 | Feb 2026 | 5,799 | $19K | 0.03% | EC |
| 231 | Immuneering Corp. | 45254E107 | Feb 2026 | 3,615 | $18K | 0.02% | EC |
| 232 | Foghorn Therapeutics Inc. | 344174107 | Feb 2026 | 3,158 | $18K | 0.02% | EC |
| 233 | Cabaletta Bio, Inc. | 12674W109 | Feb 2026 | 5,395 | $18K | 0.02% | EC |
| 234 | Aclaris Therapeutics, Inc. | 00461U105 | Feb 2026 | 6,047 | $17K | 0.02% | EC |
| 235 | AC Immune S.A. | H00263105 | Feb 2026 | 5,590 | $16K | 0.02% | EC |
| 236 | Candel Therapeutics, Inc. | 137404109 | Feb 2026 | 3,078 | $16K | 0.02% | EC |
| 237 | Puma Biotechnology, Inc. | 74587V107 | Feb 2026 | 2,824 | $16K | 0.02% | EC |
| 238 | Evolus, Inc. | 30052C107 | Feb 2026 | 3,626 | $16K | 0.02% | EC |
| 239 | Aardvark Therapeutics, Inc. | 002942100 | Feb 2026 | 1,232 | $15K | 0.02% | EC |
| 240 | Lifecore Biomedical, Inc. | 514766104 | Feb 2026 | 2,092 | $15K | 0.02% | EC |
| 241 | Bicycle Therapeutics PLC | 088786108 | Feb 2026 | 2,589 | $15K | 0.02% | EC |
| 242 | Vor BioPharma Inc. | 929033207 | Feb 2026 | 960 | $15K | 0.02% | EC |
| 243 | C4 Therapeutics, Inc. | 12529R107 | Feb 2026 | 5,430 | $15K | 0.02% | EC |
| 244 | Silence Therapeutics PLC | 82686Q101 | Feb 2026 | 2,621 | $14K | 0.02% | EC |
| 245 | OmniAb, Inc. | 68218J103 | Feb 2026 | 8,054 | $14K | 0.02% | EC |
| 246 | Orchestra Biomed Holdings, Inc. | 68572M106 | Feb 2026 | 3,155 | $14K | 0.02% | EC |
| 247 | Arcturus Therapeutics Holdings Inc. | 03969T109 | Feb 2026 | 1,610 | $13K | 0.02% | EC |
| 248 | Voyager Therapeutics, Inc. | 92915B106 | Feb 2026 | 3,162 | $13K | 0.02% | EC |
| 249 | Humacyte, Inc. | 44486Q103 | Feb 2026 | 10,465 | $12K | 0.02% | EC |
| 250 | Editas Medicine, Inc. | 28106W103 | Feb 2026 | 5,197 | $11K | 0.02% | EC |
| 251 | Coherus Oncology, Inc. | 19249H103 | Feb 2026 | 6,762 | $11K | 0.01% | EC |
| 252 | Quantum-Si Inc. | 74765K105 | Feb 2026 | 10,933 | $10K | 0.01% | EC |
| 253 | Sagimet Biosciences Inc. | 786700104 | Feb 2026 | 1,749 | $10K | 0.01% | EC |
| 254 | Caribou Biosciences, Inc. | 142038108 | Feb 2026 | 5,225 | $10K | 0.01% | EC |
| 255 | Jyong Biotech Ltd. | G83116106 | Feb 2026 | 4,238 | $9K | 0.01% | EC |
| 256 | Black Diamond Therapeutics, Inc. | 09203E105 | Feb 2026 | 3,178 | $8K | 0.01% | EC |
| 257 | Alpha Teknova, Inc. | 02080L102 | Feb 2026 | 2,973 | $8K | 0.01% | EC |
| 258 | Rani Therapeutics Holdings, Inc. | 753018100 | Feb 2026 | 5,458 | $7K | 0.01% | EC |
| 259 | Gossamer Bio, Inc. | 38341P102 | Feb 2026 | 12,911 | $5K | 0.01% | EC |
| 260 | Codexis, Inc. | 192005106 | Feb 2026 | 5,176 | $5K | 0.01% | EC |
| 261 | Tenaya Therapeutics, Inc. | 87990A106 | Feb 2026 | 9,284 | $5K | 0.01% | EC |
| 262 | Pyxis Oncology, Inc. | 747324101 | Feb 2026 | 3,526 | $5K | 0.01% | EC |
| 263 | Cartesian Therapeutics, Inc. | 816212112 | Feb 2026 | 2,633 | $359 | 0.00% | EC |
| 264 | Third Harmonic Bio, Inc. | 88427A107 | Feb 2026 | 1,661 | $50 | 0.00% | EC |
| 265 | OmniAb, Inc. | 68218J202 | Feb 2026 | 125 | $0 | 0.00% | EC |
| 266 | OmniAb, Inc. | 68218J301 | Feb 2026 | 125 | $0 | 0.00% | EC |
| 267 | Novo Nordisk A/S | NOVOB CVR | Feb 2026 | 3,794 | $0 | 0.00% | EC |